Stockreport

Coya Therapeutics Reports Statistically Significant Improvement of Inflammatory Blood Markers in Patients with Alzheimer's Disease Following Monthly Dosing with Low-Dose IL-2, Further Supp...

Coya Therapeutics, Inc.  (COYA) 
PDF Business Wire Thu, February 6, 2025 at 2:00 PM GMT+1 11 min read In This Article COYA Investigator-initiated data from Houston Methodist Hospital showed LD IL [Read more]